Sciencemag: C-Path Opens Access To Duchenne Regulatory Science Consortium Database

Scienmag: C-Path Opens Access To Duchenne Regulatory Science Consortium Database. “Critical Path Institute (C-Path) announced today that it will open access to the Duchenne Regulatory Science Consortium (D-RSC) database to qualified researchers, through its Rare Disease Cures Accelerator, Data and Analytics Platform (RDCA-DAPĀ®). The D-RSC database includes data from Duchenne muscular dystrophy (DMD) clinical trials, natural history studies and clinical data collections. The contributors of these datasets have given permission for this data to be shared externally to accelerate therapy development for DMD. DMD is a rare, fatal, genetic neuromuscular disorder that is diagnosed in childhood and primarily affects males.”